Sean Fetcho is the co-founder and CEO of Verséa Health, the parent company of Verséa Discovery, the creators of mescreen™.

Sean Fetcho leads with a clear vision: to revolutionize health optimization by putting mitochondrial testing at the forefront of preventative care. With a focus on innovation and accessibility, Sean's leadership drives mescreen's mission to empower individuals with actionable insights for improved longevity and vitality. By fostering a dynamic culture of collaboration and forward-thinking, he ensures mescreen stays ahead in delivering groundbreaking health solutions, redefining the landscape of personalized healthcare.

Sean successfully created, launched, and oversaw 8 highly successful print and digital publication that targeted oncology, pain management and cardiology professionals, all of which remain in circulation today. He was then recruited into a Continuing Medical Education (CME) company where Sean developed and executed on new revenue streams that helped structure the business for an exit. Within 3 years, Aventine (PAINWeek) sold to a publicly traded company on the London Stock Exchange.

In his earlier years before healthcare, Sean was part of the launch team for Red Bull USA and a co-founder in a revolutionary packaging company that sustains the shelf-life of perishables all while killing off any food borne pathogens while in transit.

Sean attended University of Westminster and Towson University with degrees in Economics & Psychology. He participated in Columbia University’s School of Business training programs for executives and advanced training in Neuro-Linguistic Programming, Urgency-Based Selling, Strategic Intuition, Management, Sales, and Business Development.

Sean is an avid traveler for both business and pleasure and is thankful to have been to all 50 US states and 90+ countries. In his spare time, he enjoys playing the drums, snowboarding, tennis, basketball and spending time with his family & friends, especially his son Zeppelin!